Join to View Full Profile
1595 E River Rdunit 202Tucson, AZ 85718
Phone+1 520-694-2020
Dr. Jedlowski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Patrick Jedlowski, based in Tucson, AZ, specializes in Dermatology with a subspecialty in Dermatologic Surgery. He completed his medical education with a residency in Dermatology and a fellowship in Micrographic Surgery and Dermatologic Oncology at the University of Arizona College of Medicine-Tucson.
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Micrographic Surgery and Dermatologic Oncology, 2024 - 2025- University of Arizona College of Medicine-TucsonResidency, Dermatology, 2021 - 2024
TMC Health Medical Education , Inc. (THMEP)Internship, Transitional Year, 2020 - 2021- University of Arizona College of MedicineClass of 2020
Certifications & Licensure
AZ State Medical License 2024 - 2028
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Resident of Distinction - 2023 dermMentors, 2023
- Most Cited Paper 2022 - Journal of Dermatology Japanese Dermatological Association, 2022
- Everett C. Fox MD Memorial Award American Academy of Dermatology, 2021
- Join now to see all
Clinical Trials
- Sham LaserCap vs. LaserCap SD vs. LaserCap HD+ Start of enrollment: 2022 Jun 01
Publications & Presentations
PubMed
- TNF-α Inhibitor Associated Psoriasis in Rheumatoid Arthritis and Inflammatory Bowel Disease Patients: A Disproportionality Analysis Using the FDA Adverse Event Reporti...Zachary Leibovit-Reiben, Hannah Godfrey, Patrick Jedlowski, Rebecca Thiede
Journal of Cutaneous Medicine and Surgery. 2025-06-08 - Neurologic adverse events associated with BRAF and MEK inhibitor therapy in patients with malignant melanoma: a disproportionality analysis using the Food and Drug Adm...Zachary Leibovit-Reiben, Hannah Godfrey, Patrick Jedlowski, Rebecca Thiede
Melanoma Research. 2025-04-01 - 7 citationsAlopecia associated with the use of semaglutide and tirzepatide: A disproportionality analysis using the FDA adverse event reporting system (FAERS) from 2022 to 2023.Hannah Godfrey, Zachary Leibovit-Reiben, Patrick Jedlowski, Rebecca Thiede
Journal of the European Academy of Dermatology and Venereology. 2025-02-01
Journal Articles
- Evaluation and Treatment of Acute and Subacute Hearing Loss: A Review of PharmacotherapyPatrick M Jedlowski, Maryam T Fazel, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Press Mentions
Erythema Multiforme Major Due to Fluconazole: A Case ReportMarch 4th, 2023- Exploring Patient-Reported Outcomes Measures in Atopic DermatitisMarch 4th, 2023
Professional Memberships
- Fellow
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
